Thirteen patients were treated surgically, 6 by transfrontal (Professor Valentine Logue) and 7 by transsphenoidal (Mr R A Williams) hypophysectomy. Two patients with marked changes of acromegaly had clinically inactive disease. In one this was attributed to previous external radiotherapy (6,000 r) but the other apparently represented the condition of 'burnt out' acromegaly.
The basal plasma GH levels of individual patients were found to vary widely from day to day and in 6 patients who had 2+-hour saline infusions there were marked fluctuations about the mean level. The mean fasting plasma GH levels were related to the degree of physical disfigurement. In severe cases the levels exceeded 100 ng/ml, in mild cases they were in the range 10-30 ng/ml. The patient with 'burnt out' acromegaly had a mean fasting GH level of 3 5 ng/ml. After operation the spontaneous fluctuations in the fasting levels of GH persisted but the mean levels had fallen by 40% or more in 11 patients and in 5 of these to 5 ng/ml or less. GH levels in one patient, which rose after partial removal of an invasive tumour, subsequently fell after X-ray therapy (4,000 r).
All patients had intravenous glucose (25 g) and 6 had oral glucose (50 g) tests at the time of diagnosis. A partial reduction of GH levels was observed in 4 patients but in all the area under the GH curve (Sonksen et al. 1967) was above the range found in 12 normal subjects. A rise of GH levels after glucose was observed in 3 patients, in one to oral, but not to intravenous glucose before and after surgery in spite of a tenfold reduction in basal GH levels.
Intravenous glucose tests were repeated in all patients after operation and in only one was the GH level suppressed. The area under the GH curve after intravenous glucose was reduced appreciably by operation in 12 patients but in only 4 to within the range found in normal subjects.
Intravenous insulin tests (0-3-0-6 units/kg body weight) were performed on 11 patients pre-operatively and 7 responded with a rise in GH levels. Six of the 11 patients (including 3 'non-responders') were retested after operation and all had a significant elevation of GH levels in response to hypoglycemia. In one patient the highest levels of GH recorded were during the post-operative insulin test.
Two untreated patients had GH measurements during intravenous glucose tests at intervals over a three-year period. The area under the GH curve increased during the period of observation. Eight patients treated surgically were followed for periods of up to four years. In 6 the area under the GH curve in the first post-operative intravenous glucose test (one to three months after operation) was similar to the value obtained at the end of the period of follow up. One patient referred to previously responded to X-ray therapy; in the other, despite an increase in GH levels there had been no clinical evidence of progress of the disease.
Measurements of plasma GH levels have shown disordered regulation of GH secretion as well as raised fasting levels in acromegaly. After surgical treatment the fasting plasma GH levels usually fell but seldom to the normal range. In some patients the disordered regulation of secretion was partly corrected. Cryogenic surgery, the destruction of tissues by intense cold, was introduced into medicine by Cooper in 1963 and has since found application in many fields. It produces death of cells by a combination of effects, among which rupture of membranes, crystallization and ischimia are probably important. One of its uses has been in the treatment of functioning pituitary tumours and ablation of the normal pituitary gland. The technique uses liquid nitrogen at temperatures as low as -196°C, which is delivered to the pituitary gland via a cannula inserted under stereotaxic control through drill holes into the pituitary fossa (Rand et a. 1964) . The duration of freezing and the number of lesions made depend on the size of the gland, and it should be possible to predict accurately the size of the lesion produced if the 'Dr Harrison died in June 1969 In the case of functioning pituitary tumours, experience has been almost confined to those producing acromegaly; of 41 reported patients in several series, 36 (88 Y.) have had clinical remission with loss of headache, paristhesia and sweating. Shrinking of soft tissue may be obvious within a few days, and there may be a rapid fall in levels of serum growth hormone, values reaching normal levels within two days (Lazarus et al. 1966) . More gradual falls occur in some patients and gradual improvement continues, but relapse occurs in others, and the clinical course does not always correlate with changes in growth hormone levels.
The one common complication of pituitary cryogenic surgery is diabetes insipidus, which has occurred in about 30% of patients reported. It may or may not be permanent. The probable explanation is that cold is conducted up the pituitary stalk to the hypothalamus, whereas the rapidly flowing blood in the cavernous sinus protects the structures there and the cerebrospinal fluid insulates the optic chiasma. Less commonly, rhinorrheea and meningitis have followed surgery and a few deaths from cardiac arrest have occurred, almost wholly in patients with diabetic retinopathy.
In Glasgow, 15 patients with functioning pituitary tumours have been treated by cryogenic surgery. One acromegalic patient had dramatic remission of headache and parmsthesia, and there was evidence of soft tissue shrinkage within five days. Levels of serum growth hormone remained elevated (Table 1 ) but there was evidence of partial response to hyperglycaemia post-operatively, suggesting that the growth-hormone-producing cells had become responsive to normal homceostatic control.
In a patient with Cushing's syndrome and a pituitary tumour elevated levels of plasma cortisol fell to normal over an eighteen-month period and the response of urinary 17-hydroxycorticoids to metyrapone decreased after cryogenic surgery. Headache, bruising and hypertension improved.
The most successful result from cryogenic surgery was obtained in a patient with Nelson's syndrome, an MSH-secreting pituitary tumour which developed after total adrenalectomy for Cushing's syndrome. A pituitary implant with yttrium 90 at another hospital had previously been unsuccessful. Three months after adrenalectomy he developed gross pigmentation, headache, and visual field defect. Plasma ,-MSH (Dr K Abe, Department of Medicine, University of Tennessee) was 240 pg/ml (normal range 0-80 pg/ml). After cryogenic pituitary surgery the pigmentation disappeared completely over the next six months and the level of plasma P-MSH fell to 60 pg/ml. This patient developed diabetes insipidus six months after cryogenic surgery, and this has persisted.
Summary
Cryogenic surgery can be useful in the treatment of functioning pituitary tumours and in ablation of the normal gland. It is not a major operative procedure and has the advantages of predictability and rapid effect, while it may be repeated as often as necessary. A common complication, however, is diabetes insipidus, which occurs in about onethird of the patients. Our early observations indicate that slowly progressive pituitary failure may ensue, so that careful supervision of these patients is necessary for a long period postoperatively.
